Stockreport

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million [Yahoo! Finance]

Evoke Pharma, Inc.  (EVOK) 
Last evoke pharma, inc. earnings: 11/7 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: evokepharmainc.gcs-web.com/investor-overview
PDF treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced today that it has priced an underwritten public offeri [Read more]